Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration

Document Details

Document Type
Pub Defense Publication
Publication Date
Feb 01, 2021
Source ID
10.1016/j.jconrel.2020.11.017

Entities

People

  • Daniel Shae
  • Jessalyn J. Baljon
  • John T Wilson
  • Justin M. Balko
  • Kelli L. Boyd
  • Kyle W Becker
  • Lihong Wang-bishop
  • Mohamed Wehbe
  • Plamen Christov
  • Xinyi He

Organizations

  • American Association for Cancer Research
  • Congressionally Directed Medical Research Programs
  • Melanoma Research Alliance
  • National Institutes of Health
  • National Science Foundation
  • Susan G. Komen for the Cure

Tags

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech